<VariationArchive RecordType="classified" VariationID="37003" VariationName="NM_000077.5(CDKN2A):c.19_23dup (p.Ser8fs)" VariationType="Duplication" Accession="VCV000037003" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-12-25" DateCreated="2017-08-20" MostRecentSubmission="2017-08-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="45669" VariationID="37003">
      <GeneList>
        <Gene Symbol="CDKN2A" FullName="cyclin dependent kinase inhibitor 2A" GeneID="1029" HGNC_ID="HGNC:1787" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>9p21.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="9" Accession="NC_000009.12" start="21967752" stop="21995324" display_start="21967752" display_stop="21995324" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="9" Accession="NC_000009.11" start="21967750" stop="21994489" display_start="21967750" display_stop="21994489" Strand="-" />
          </Location>
          <OMIM>600160</OMIM>
          <Haploinsufficiency last_evaluated="2022-03-18" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=CDKN2A">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2022-03-18" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=CDKN2A">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_000077.5(CDKN2A):c.19_23dup (p.Ser8fs)</Name>
      <CanonicalSPDI>NC_000009.12:21974804:CTGCTC:CTGCTCTGCTC</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>9p21.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="9" Accession="NC_000009.12" start="21974804" stop="21974805" display_start="21974804" display_stop="21974805" variantLength="5" positionVCF="21974804" referenceAlleleVCF="G" alternateAlleleVCF="GCTGCT" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="9" Accession="NC_000009.11" start="21974803" stop="21974804" display_start="21974803" display_stop="21974804" variantLength="5" positionVCF="21974803" referenceAlleleVCF="G" alternateAlleleVCF="GCTGCT" />
      </Location>
      <ProteinChange>S8fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000009.11" sequenceAccession="NC_000009" sequenceVersion="11" change="g.21974805_21974809dup" Assembly="GRCh37">
            <Expression>NC_000009.11:g.21974805_21974809dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000009.12" sequenceAccession="NC_000009" sequenceVersion="12" change="g.21974806_21974810dup" Assembly="GRCh38">
            <Expression>NC_000009.12:g.21974806_21974810dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007485.1" sequenceAccession="NG_007485" sequenceVersion="1" change="g.24683_24687dup">
            <Expression>NG_007485.1:g.24683_24687dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000077.5" sequenceAccession="NM_000077" sequenceVersion="5" change="c.19_23dup" MANESelect="true">
            <Expression>NM_000077.5:c.19_23dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000068.1" sequenceAccession="NP_000068" sequenceVersion="1" change="p.Ser8fs">
            <Expression>NP_000068.1:p.Ser8fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001195132.2" sequenceAccession="NM_001195132" sequenceVersion="2" change="c.19_23dup">
            <Expression>NM_001195132.2:c.19_23dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001182061.1" sequenceAccession="NP_001182061" sequenceVersion="1" change="p.Ser8fs">
            <Expression>NP_001182061.1:p.Ser8fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_058197.5" sequenceAccession="NM_058197" sequenceVersion="5" change="c.19_23dup">
            <Expression>NM_058197.5:c.19_23dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_478104.2" sequenceAccession="NP_478104" sequenceVersion="2" change="p.Ser8fs">
            <Expression>NP_478104.2:p.Ser8fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001363763.2" sequenceAccession="NM_001363763" sequenceVersion="2" change="c.-3-3601_-3-3597dup">
            <Expression>NM_001363763.2:c.-3-3601_-3-3597dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_058195.4" sequenceAccession="NM_058195" sequenceVersion="4" change="c.194-3601_194-3597dup" MANEPlusClinical="true">
            <Expression>NM_058195.4:c.194-3601_194-3597dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_11" sequenceAccession="LRG_11">
            <Expression>LRG_11:g.24683_24687dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_11t1" sequenceAccession="LRG_11t1">
            <Expression>LRG_11t1:c.19_23dup</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="600160.0022" DB="OMIM" />
        <XRef Type="rs" ID="2131114005" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000077.5(CDKN2A):c.19_23dup (p.Ser8fs) AND Melanoma-pancreatic cancer syndrome" Accession="RCV000030680" Version="6">
        <ClassifiedConditionList TraitSetID="2587">
          <ClassifiedCondition DB="MedGen" ID="C1838547">Melanoma-pancreatic cancer syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2012-06-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2012-06-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2017-08-20" MostRecentSubmission="2017-08-20">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">22636603</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="2587" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2742" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Melanoma-pancreatic cancer syndrome</ElementValue>
                <XRef ID="Melanoma-pancreatic+cancer+syndrome/8812" DB="Genetic Alliance" />
                <XRef ID="MONDO:0011713" DB="MONDO" />
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="18473" />
                <XRef ID="18473" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Melanoma-pancreatic cancer syndrome is an inherited cancer predisposition syndrome in which mutation carriers have an increased risk of developing malignant melanoma and/or pancreatic cancer. Mutation carriers within families may develop either or both types of cancer (summary by Harinck et al., 2012).
For background and phenotypic information on malignant melanoma and pancreatic cancer, see 155600 and 260350, respectively.</Attribute>
                <XRef Type="MIM" ID="606719" DB="OMIM" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000528916" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000530028" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000569524" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000530120" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000530202" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000552245" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000569916" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000570011" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000325625" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501426" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000502978" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <Citation Type="general" Abbrev="CAPS, 2013">
                <ID Source="pmc">3585492</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACG, 2015">
                <ID Source="PubMed">25645574</ID>
              </Citation>
              <Citation Type="general" Abbrev="CAPS, 2020">
                <ID Source="PubMed">31672839</ID>
                <ID Source="pmc">7295005</ID>
              </Citation>
              <XRef ID="404560" DB="Orphanet" />
              <XRef ID="C1838547" DB="MedGen" />
              <XRef ID="MONDO:0011713" DB="MONDO" />
              <XRef Type="MIM" ID="606719" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="88208" SubmissionDate="2017-08-17" DateLastUpdated="2017-08-20" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="600160.0022_MELANOMA-PANCREATIC CANCER SYNDROME" title="CDKN2A, 5-BP DUP, NT19_MELANOMA-PANCREATIC CANCER SYNDROME" />
        <ClinVarAccession Accession="SCV000053341" DateUpdated="2017-08-20" DateCreated="2013-04-04" Type="SCV" Version="3" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2012-06-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In 3 members of a family of Indonesian descent with pancreatic cancer (606719), Harinck et al. (2012) identified a heterozygous 5-bp duplication (19_23dup) in the CDKN2A gene, resulting in a frameshift and premature termination. Although there were no cases of melanoma in this family, Harinck et al. (2012) noted that the dark skin of the individuals may have offered protection from developing melanoma.</Attribute>
              <Citation>
                <ID Source="PubMed">22636603</ID>
              </Citation>
              <XRef DB="OMIM" ID="606719" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CDKN2A" />
          </GeneList>
          <Name>CDKN2A, 5-BP DUP, NT19</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">5-BP DUP, NT19</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="600160.0022" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">MELANOMA-PANCREATIC CANCER SYNDROME</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="88208" TraitType="Disease" MappingType="Name" MappingValue="MELANOMA-PANCREATIC CANCER SYNDROME" MappingRef="Preferred">
        <MedGen CUI="C1838547" Name="Melanoma-pancreatic cancer syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

